Beifuxin is commercially available under the generic name Recombinant Bovine Basic Fibroblast Growth Factor Topical Gel. 6-month-old babies with facial eczema can be treated by applying this product when fresh wounds are present, thereby promoting localized healing, but if you want to simply improve the symptoms of dryness and itchiness, the results of the drug alone may not always be very satisfactory. The indication for recombinant bovine basic fibroblast growth factor topical gel is to promote wound healing, and it can be used for burn wounds (including shallow II degree, deep II degree, and granulation wounds), chronic wounds (including chronic ulcers on the body surface, etc.), and fresh wounds (including traumatic injuries, donor area wounds, and surgical wounds, etc.). 6 months baby facial eczema during excessive scratching, if there will be localized wounds, can be applied by applying this product, so as to promote the healing of wounds. However, this product is not to be used as the first-line medicine for eczema. For eczema diseases, topical medications such as basic moisturizing skin care agents and glucocorticosteroids are also required. It is recommended that after the diagnosis of pediatric eczema, you should cooperate with your doctor to carry out standardized treatment, do not blindly use drugs to avoid adverse effects.